DYNE THERAPEUTICS INC (DYN)

US26818M1080 - Common Stock

15  -0.29 (-1.9%)

After market: 15 0 (0%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
314.47M242.16M170.96M150.03M58.65M
Research and Development
258.45M210.76M142.76M121.31M45.20M
Selling, General, and Administrative Expenses
56.02M31.40M28.20M28.72M13.45M
Operating Income
-314.47M-242.16M-170.96M-150.03M-58.65M
Interest Income/Expense
21.08M7.64M2.92M740.00K-340.00K
Other Income/Expense
-1.13M-1.42M-50.00K-10.00K-450.00K
Income Before Taxes
-294.51M-235.94M-168.10M-149.29M-59.44M
Net Income
-294.51M-235.94M-168.10M-149.29M-59.44M
EBITDA
-312.84M-240.49M-169.28M-148.94M-57.95M
 
Per Share Data
EPS Diluted Total Ops
-3.56-3.95-3.23-2.93-1.32
Non GAAP EPS
-3.56-3.94-3.24-2.91N/A
 
Statistics

All data in USD

Charts